← SynDRA
R-406
SynDRA canonical compound SYN0012016 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | SYK |
|---|
| Mechanism of action | FLT3 inhibitor |
|---|
All known targets
- SYK
- RET
- FLT3
- DAPK2
- JAK3
- MST1R
- ABCG2
- PDGFRB
- ABL1
- KIT
- EGFR
- SRC
Mechanisms of action (all sources)
- SYK INHIBITOR
- FLT3 INHIBITOR
- RET INHIBITOR
- SYK MODULATOR
- Tyrosine-protein kinase SYK inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
ATC classes
- B02B · VITAMIN K AND OTHER HEMOSTATICS
Cross-references
Synonyms
- R940406
- Tamatinib
- tamatinib
- R406 free base
- R 406
- RC3A285J2G
- RefChem:891058
- DTXCID20409758
- R406 (free base)
- Tamatinib free base
- MFCD09970820
- R406(free base)
- BDBM50249542
- C22H23FN6O5
- 3fqs
- 3piy
- R 406 free base
- R406 free base?
- Kinome_1211
- UNII-RC3A285J2G
- MLS006011151
- GTPL5706
- orb1305445
- SCHEMBL1200144
- SCHEMBL29358236
- BDBM60665
- CHEBI:91348
- EX-A103
- NHHQJBCNYHBUSI-UHFFFAOYSA-N
- GLXC-90301
- HMS3265G15
- HMS3265G16
- HMS3265H15
- HMS3265H16
- HMS3654F22
- NSC772498
- NSC800858
- s1533
- AKOS015951111
Look up R-406 in the interactive SynDRA portal →